ParcelBio

Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.

PMV mark · valuation
$41.2M
Oct 2026
Priced at
its seed round
Mar 2026
Total raised
$13.7M
Last round
Seed Round
May 2024

Who backs ParcelBio?

13 investors
InvestorType
Y CombinatorOther
Alumni VenturesVenture capital
Pioneer FundVenture capital
Metaplanet HoldingsVenture capital
468 CapitalVenture capital
SBXiVenture capital
Spacecadet VenturesVenture capital
ZAKA VCVenture capital
Ritual CapitalVenture capital
SurgePoint CapitalVenture capital
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ParcelBio investors

13 investors are on record for ParcelBio, including Y Combinator, Alumni Ventures, Pioneer Fund and Metaplanet Holdings. By type, the record holds 9 venture capital firms. The seed round in May 2024 drew 11 investors.

Free account
More of ParcelBio with a free account
  • ·The complete investor list: 13 names
  • ·Watch ParcelBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like ParcelBio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View